Cue Biopharma (STU:1UC) Book Value per Share : €0.57 (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Cue Biopharma Book Value per Share?

Cue Biopharma's book value per share for the quarter that ended in Mar. 2024 was €0.57.

During the past 12 months, Cue Biopharma's average Book Value Per Share Growth Rate was -51.50% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -32.90% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -12.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 9 years, the highest 3-Year average Book Value Per Share Growth Rate of Cue Biopharma was 69.70% per year. The lowest was -32.90% per year. And the median was 1.45% per year.

Cue Biopharma's current price is €1.47. Its book value per share for the quarter that ended in Mar. 2024 was €0.57. Hence, today's PB Ratio of Cue Biopharma is 2.59.

During the past 9 years, the highest P/B Ratio of Cue Biopharma was 17.69. The lowest was 1.45. And the median was 4.09.

Cue Biopharma Book Value per Share Historical Data

The historical data trend for Cue Biopharma's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cue Biopharma Book Value per Share Chart

Cue Biopharma Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Book Value per Share

Get a 7-Day Free Trial

1.85

2.14

1.80

1.44

0.72

Cue Biopharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Book Value per Share	Get a 7-Day Free Trial															1.19	0.97	0.89	0.72	0.57

Competitive Comparison of Cue Biopharma's Book Value per Share

For the Biotechnology subindustry, Cue Biopharma's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cue Biopharma's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cue Biopharma's PB Ratio distribution charts can be found below:

* The bar in red indicates where Cue Biopharma's PB Ratio falls into.

Cue Biopharma Book Value per Share Calculation

Cue Biopharma's Book Value Per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Book Value Per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(34.01	-	0.00)	/	47.22
	=	0.72

Cue Biopharma's Book Value Per Share for the quarter that ended in Mar. 2024 is calculated as:

Book Value Per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(27.64	-	0.00)	/	48.64
	=	0.57

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.

Cue Biopharma (STU:1UC) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.

Cue Biopharma Book Value per Share Related Terms

Thank you for viewing the detailed overview of Cue Biopharma's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Cue Biopharma (STU:1UC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cue Biopharma Inc (STU:1UC) » Definitions » Book Value per Share

Comparable Companies

Traded in Other Exchanges

CUE:USA

Address

40 Guest Street, Boston, MA, USA, 02135

Website

https://www.cuebiopharma.com

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its drug candidate comprises CUE-101, a variant form of the cytokine Interleukin-2 and a T cell antigen to target and activate T cells specific to HPV-related cancers. The other products under pipeline are CUE-102, CUE-103, CUE-400, and CUE-401.

Cue Biopharma (STU:1UC) Headlines

No Headlines